Citius Oncology, Inc. - Common Stock CTOR 深 滬
已收盤 10-24 16:00:00 美东时间
1.72
+0.050
+2.99%
華盛通- 最 高1.7801
- 今 開1.69
- 成交量 16.68万股
- 最 低 1.67
- 昨 收 1.67
- 總市值 1.35亿
- 52周最高 6.19
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 0.5506
- 委 比 74.98%
- 總股本 7837.06万
- 歷史最高 49.00
- 量 比 0.43
- 振 幅 6.59%
- 歷史最低 0.00
- 每 手 1
- 風險率 0.78%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多【华鑫电子通信|行业周报】第二届湾芯展成功举办，ASML、台积电Q3业绩大增
（来源：华鑫研究） ▌ 上周回顾 10月13日-10月17日当周，申万一级行业涨跌呈分化的态势。其中电子行业下跌7.14%，位列第31位。估值前三...
10-21 11:00
Citius Oncology Announced It Has Finalized An Exclusive Agreement With EVERSANA To Support The Q4 2025 U.S. Commercialization Of LYMPHIR
EVERSANA to provide integrated commercialization services, enhancing launch readiness and market entry for differentiated Cutaneous T-cell Lymphoma therapyCRANFORD, N.J., Oct. 16, 2025 /PRNewswire/ -- Citius
10-16 20:52
Breakthrough Discoveries Unlock $643B Cancer Treatment Market By 2034
Equity Insider News Commentary Issued on behalf of GT Biopharma, Inc. VANCOUVER, BC, Oct. 8, 2025 /PRNewswire/ -- Ohio State researchers recently solved a critical mystery explaining why som...
10-08 22:58
PRAGMATIC SEMICONDUCTOR APPOINTS PETER HERWECK AS CHAIR TO BOARD OF DIRECTORS
Industrial technology veteran joins the FlexIC technology pioneer enabling item-level intelligence at scale that bridges our physical and digital worlds for a sustainable future. CAMBRIDGE, ...
10-07 14:00
Beer, Lesbians and Baseball! Casting Announced for New Crave Original Comedy Series, SLO PITCH
– The series stars Jess Salgueiro, Karen Knox, Gwenlyn Cumyn, Emma Hunter, and Emily Hampshire, with special guest star, women's softball legend Ayami Sato – – Shooting now in Toronto, Hami...
10-02 23:55
Q3 Virtual Investor Summit: On-Demand Presentations Now Available
NEW YORK, NY / ACCESS Newswire / September 30, 2025 / Investor Summit Group is ...
10-01 01:00
美股大行评级 | 升至450美元，瑞穗上调特斯拉目标价；富国银行上调CoreWeave至"超配"，目标价升至170美元
今日重点评级关注：Guggenheim：维持MBX Biosciences"买入"评级，目标价从44美元升至84美元；Oppenheimer：维持MBX Biosciences"跑赢大市"评级，目标价从38美元升至80美元
09-24 10:23
Maxim Group Upgrades Citius Oncology to Buy, Announces $6 Price Target
Maxim Group analyst Michael Okunewitch upgrades Citius Oncology (NASDAQ:CTOR) from Hold to Buy and announces $6 price target.
09-23 19:47
Citius Oncology Issues Warrants in Private Placement
Citius Oncology ( ($CTOR) ) has provided an announcement. On September 19, 2025...
09-20 05:33
Sivers Semiconductors intends to carry out a directed share issue
NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, BELARUS, SINGAPORE, SOUTH AFRICA, SO...
09-19 00:17
